NewsRx

Search our medical news database

Tissue Engineering

Research on tissue engineering reported by scientists at Austin Hospital

Published in Medical Patent Business Week, November 16th, 2007

"The Radial Artery Patency and Clinical Outcomes ( RAPCO) study has enrolled patients into two trials to compare the radial artery with the free right internal thoracic artery ( if age < 70 years) or with saphenous vein ( if age > 70 years) when grafted onto the largest target other than the left anterior descending artery. Patency outcomes in RAPCO will focus only on the trial graft in each case," scientists writing in the journal Annals of Thoracic Surgery report.

"However, postoperative angiography from this ongoing study has reassessed all coronary grafts, both trial and nontrial: together these offer a valuable observational overview of likely graft...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook